A novel crystal form (form II) of the benzodiazepine chlordiazepoxide
is reported. The new polymorphic phase was characterized and distingui
shed from the standard form (form I) by X-ray diffractometry, differen
tial scanning calorimetry, infrared spectroscopy, microscopy, solution
calorimetry, and solid-state nuclear magnetic resonance. The formatio
n of form II was dependent on the crystallizing solvent, being the pre
dominant form isolated from methanol. Recrystallization from other alc
oholic solutions (ethanol, propanol, and butanol) and toluene yielded
form I. Differential scanning calorimetry and powder X-ray diffraction
indicated that the two forms were enantiotropically related with a tr
ansition of form II to form I occurring between 200 and 225 degrees C.
Visual examination by hot stage microscopy in this temperature range
revealed a dramatic solid-state transition. Single-crystal X-ray analy
sis was performed on form II which was found to crystallize in the tri
clinic space group P (I) over bar with a = 10.736(2) Angstrom, b = 16.
921(4) Angstrom, c = 17.041(4) Angstrom, alpha = 100.76(1)degrees, bet
a = 95.27(1)degrees, gamma = 97.53(1)degrees, Z = 8, and d(cal) = 1.33
g/cm(3). When compared with the published crystal structure of form I
, the cell symmetry, volume, and density were similar. Both structures
consisted of four crystallographically independent molecules linked i
n pairs through intermolecular hydrogen bonding. Differences were obse
rved in the packing arrangement of the dimers in the polymorphs. The s
mall heat of transition calculated from solution calorimetry (1.5 kJ m
ol(-1)) was sufficient to effect a crystallographic rearrangement of t
he dimers.